Oncocyte Publishes Study Demonstrating Predictive Potential
Data show that DetermaIO demonstrates superior accuracy compared to standard of care PD-L1 IHC for predicting a patient’s response to immunotherapy...
Source: globenewswire.com
Stay updated with breaking news from Neoadjuvant Immunochemotherapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data show that DetermaIO demonstrates superior accuracy compared to standard of care PD-L1 IHC for predicting a patient’s response to immunotherapy...